Dexamethasone in Total Knee Arthroplasty
Public ClinicalTrials.gov record NCT05018091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dexamethasone in Total Knee Arthroplasty: What Dose Should we be Giving Patients Intraoperatively
Study identification
- NCT ID
- NCT05018091
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Rush University Medical Center
- Other
- Enrollment
- 404 participants
Conditions and interventions
Conditions
Interventions
- Dexamethasone 16mg Drug
- Dexamethasone 4mg Drug
- Dexamethasone 8 Mg/mL Injectable Suspension Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2021
- Primary completion
- Dec 31, 2024
- Completion
- May 29, 2025
- Last update posted
- Aug 2, 2025
2021 – 2025
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University | Redwood City | California | 94063 | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| Rush University medical Center | Chicago | Illinois | 60612 | — |
| Mass General Brigham | Somerville | Massachusetts | 02145 | — |
| Mayo Clinic Institutional Review | Rochester | Minnesota | 55902 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Columbia University Irving Medical Center | New York | New York | 10032 | — |
| University of Pennsylvania Perelman School of Medicine | Philadelphia | Pennsylvania | 19104 | — |
| Jefferson Philadelphia University and Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05018091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05018091 live on ClinicalTrials.gov.